chr16-67658269-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001082486.2(ACD):c.923G>A(p.Gly308Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00122 in 1,613,710 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001082486.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACD | NM_001082486.2 | c.923G>A | p.Gly308Glu | missense_variant | 10/12 | ENST00000620761.6 | NP_001075955.2 | |
ACD | NM_022914.3 | c.914G>A | p.Gly305Glu | missense_variant | 10/12 | NP_075065.3 | ||
ACD | NM_001410884.1 | c.836G>A | p.Gly279Glu | missense_variant | 9/11 | NP_001397813.1 | ||
ACD | XR_429728.4 | n.*1G>A | downstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00626 AC: 953AN: 152128Hom.: 5 Cov.: 33
GnomAD3 exomes AF: 0.00147 AC: 367AN: 250392Hom.: 1 AF XY: 0.00104 AC XY: 141AN XY: 135508
GnomAD4 exome AF: 0.000690 AC: 1008AN: 1461464Hom.: 14 Cov.: 34 AF XY: 0.000615 AC XY: 447AN XY: 727026
GnomAD4 genome AF: 0.00626 AC: 953AN: 152246Hom.: 5 Cov.: 33 AF XY: 0.00595 AC XY: 443AN XY: 74438
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 31, 2018 | - - |
Dyskeratosis congenita, autosomal dominant 6 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at